metergoline

This page covers all metergoline drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6.

Targets

5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6

Phase 2 pipeline (1)

• Liserdol · Other
  Liserdol works by binding to serotonin receptors in the brain, specifically the 5-hydroxytryptamine receptor 2C.

Patent intelligence

• metergoline patent landscape — aggregated cliff calendar, attackable patents, originator estates